Your selection
Innovation / 03.12.2024
Eckert & Ziegler: Changes in the Executive Board and Supervisory Board
The Supervisory Board of Eckert & Ziegler SE has appointed Dr. Gunnar Mann (57) as a new member of the Executive Board, effective 1 January 2025. He will assume operational responsibility for the Medical segment.
Dr. Mann who holds a doctorate in physics, joined Eckert & Ziegler in 1998 and initially started as head of development. He then served as managing director of various subsidiaries of Eckert & Ziegler SE and was appointed to the Group Executive Committee in 2011. Dr. Mann has proven expertise in the areas of radiation physics, process management and implementation of investment projects.
Jutta Ludwig, whose contract as a member of the Executive Board expires as planned on December 31, 2024 will join the Supervisory Board as a delegated member on January 1, 2025. Frank Perschmann will leave the Supervisory Board of Eckert & Ziegler SE at the end of the year.
“Dr. Mann knows Eckert & Ziegler like only few others and brings exactly the experience and expertise needed to expand production capacity in the growing medical segment and to set up facilities for new products,” explains Dr. Andreas Eckert, Chairman of the Supervisory Board of Eckert & Ziegler SE. “On behalf of the Supervisory Board, I would like to thank Mrs. Ludwig for her contribution in strengthening our position in China and I am pleased that her expertise will remain with the company. I would also like to express my thanks to Mr. Perschmann for his many years of work on the Supervisory Board and for his valuable input in the strategic development of the Group.”
About Eckert & Ziegler.
Eckert & Ziegler SE with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Source: Press Release Eckert & Ziegler
Eckert & Ziegler: Changes in the Executive Board and Supervisory Board
Overview News
News Buch Berlin
Eckert & Ziegler: Strong FY 2025 with Positive Outlook
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) set a new record in fiscal year 2025 with sales of €312.0 million. Compared to the previous year, sales rose by approximately €16 million (+5%).
more ...Launch of the Einstein Center for Early Disease Interception
At the Einstein Center for Early Disease Interception, researchers from twelve Berlin institutions will be pooling their expertise to explore new approaches to prevention, long before symptoms appear,...
more ...Strengthen international cooperation in clinical trials
As part of the Australian Clinical Trials Initiative, ACTI, Australian companies and representatives of the Australien Government’s Trade and Invest Commission, Austrade, visited the Berlin-Buch Scien...
more ...Events Buch Berlin
11.04.2026, 10:00
Geführte Wanderung durch das Stadtgut und den Schlosspark in Buch
Manfred Pinkwart lädt ein
more ...16.04.2026, 09:00
Gläsernes Labor - Unsichtbare Welten: Mikroplastik in Mensch und Natur
Vorbeikommen und mitmachen: Spannende Experimentierkurse für Kids und Megamikroskopie im Zeiss-Großplanetarium
more ...16.04.2026, 09:00
Career Day 2026: “Transition Possible: Explore Careers on Campus Buch”
Are you considering your next career step as a scientist? On April 16, the Career Day at Campus Buch invites to explore possible career paths beyond academia, hearing from professionals who have made ...
more ...
